Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| LOC/12-17 Bouguen F-IBDQ | Other Identifier | Rennes University Hospital |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of the study is to develop a validated French version of the IBDQ in a cohort of patients suffering from Inflammatory bowel diseases, namely Crohn's disease and Ulcerative Colitis.
Importance of measuring subjective aspects of the patient's health, often referred to as quality of life (QoL), become increasingly recognized and integrated into healthcare. For this purpose, The Inflammatory Bowel Disease Questionnaire (IBDQ) is a widely used questionnaire for QoL assessment specific for patients who suffer from inflammatory bowel diseases. However, the IBDQ was originally developed in a cohort of Canadian patients in English language. Since QoL is impacted by underlying cultural trends, any translation of the IBDQ should be reassessed in relation to its validity, reliability, and sensitivity to detect change in the new language and cultural context. While the linguistic French translation of the original IBDQ has been validated, the French IBDQ has never been tested adequately on a French cohort of patient that we aim to perform.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Ulcerative Colitis and Crohn's Disease |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Validation of the French Version of the Inflammatory Bowel Disease Questionnaire (IBDQ) | Other |
|
| Measure | Description | Time Frame |
|---|---|---|
| Internal validity, scale F-IBDQ | Chronbach's alpha coefficient, measured at the first visit and at the second visit. | Day1 and Month4 |
| External validity, questionnaire SF36 | Correlation with the French validated SF-36 and disease activity indexes (Harvey Bradshaw index for Crohn's disease and Simple Colitis Activity Index for ulcerative colitis, measured at the first visit and at the second visit. | Day1 and Month4 |
| Discriminant ability, disease activity indexes | Correlation with disease activity indexes, measured at the first visit and at the second visit. | Day1 and Month4 |
| Reliability, disease outcomes | Correlation with disease outcomes, measured at the first visit and at the second visit. | Day1 and Month4 |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patient with definite diagnosis of UC or CD for at least 6 months
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Guillaume Bouguen | Rennes University Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CHRU de Nancy | Nancy | France | ||||
| Service des Maladies de l'Appareil Digestif, Hôpital de Pontchaillou, 2 rue Henri Le Guilloux |
Not provided
Not provided
Not provided
Not provided
| Rennes |
| 35033 |
| France |
| ID | Term |
|---|---|
| D003093 | Colitis, Ulcerative |
| D003424 | Crohn Disease |
| D015212 | Inflammatory Bowel Diseases |
| ID | Term |
|---|---|
| D003092 | Colitis |
| D005759 | Gastroenteritis |
| D005767 | Gastrointestinal Diseases |
| D004066 | Digestive System Diseases |
| D003108 | Colonic Diseases |
| D007410 | Intestinal Diseases |
Not provided
Not provided